Opendata, web and dolomites
Horizon2020 projects coordinated by "INSTITUT CURIE"
| # | ||||
|---|---|---|---|---|
| 1 | DRUG-SEQ Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing | 2015 | 1˙999˙900.00 | 1˙999˙900.00 |
| 2 | EPOCH28 Epigenetic Profiling of Chemotherapy Efficacy | 2015 | 150˙000.00 | 150˙000.00 |
| 3 | NMJALS In vivo analysis of neuromuscular junction stability in zebrafish models of amyotrophic lateral sclerosis | 2015 | 185˙076.00 | 185˙076.00 |
| 4 | UM CURE 2020 New therapies for uveal melanoma | 2016 | 7˙971˙101.00 | 6˙183˙456.00 |
| 5 | MEMBRANE-EZRIN-ACTIN Membrane-ezrin-actin interactions mediated by ezrin binding proteins in reconstituted systems | 2016 | 173˙076.00 | 173˙076.00 |
| 6 | MAGNEURON Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stemcell therapies of neurodegenerative disorders | 2016 | 3˙473˙026.00 | 3˙473˙026.00 |
| 7 | MAIT Evolutionary conserved T cells specific for a microbial metabolite: deciphering their development in the thymus and mapping their interactions with the gut microbiota in vivo. | 2016 | 185˙076.00 | 185˙076.00 |
| 8 | FIBRO Fibroblasts in the Biology of Rectal Cancer Progression | 2016 | 173˙076.00 | 173˙076.00 |
| 9 | INTEGRISTEM Functions of Integrins in Mammary Stem Cell Activity and Tumorigenesis | 2016 | 185˙076.00 | 185˙076.00 |
| 10 | CHROMADICT Chromatin Adaptations through Interactions of Chaperones in Time | 2016 | 2˙499˙697.00 | 2˙499˙697.00 |
| 11 | CHROMATIX Role of epigenetic mechanisms in random X chromosome inactivation in vivo. | 2016 | 173˙076.00 | 173˙076.00 |
| 12 | DRUGSYNERGY DrugSynergy: A data-driven systems biology approach to optimize drug combination strategies | 2016 | 150˙000.00 | 150˙000.00 |
| 13 | IC-3I-PHD Institut Curie 3-i PhD Program | 2016 | 5˙493˙600.00 | 2˙746˙800.00 |
| 14 | STIMUNITY Preclinical validation of a novel immunogenic composition to stimulate innate immunity | 2017 | 150˙000.00 | 150˙000.00 |
| 15 | CD4CRISPR A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 | 185˙076.00 | 185˙076.00 |
| 16 | ESCRT MODEL A biophysical model for ESCRT-III mediated membrane scission | 2017 | 185˙076.00 | 185˙076.00 |
| 17 | ACTICELL Precision confiner for mechanical cell activation | 2017 | 150˙000.00 | 150˙000.00 |
| 18 | CHROMONUMBER Chromosome number variations in vivo: probing mechanisms of genesis and elimination | 2017 | 2˙000˙000.00 | 2˙000˙000.00 |
| 19 | ALTEJREPAIR Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 | 1˙498˙750.00 | 1˙498˙750.00 |
| 20 | DCBIO In vivo functions of nuclear envelope rupture and antiviral specialization in dendritic cells | 2018 | 173˙076.00 | 173˙076.00 |
| 21 | REPLICHROM4D Chromatin organization and mitotic inheritance of epigenetic states: genome-wide dynamics of H3.1 and H3.3 histone variants during DNA replication | 2018 | 173˙076.00 | 173˙076.00 |
| 22 | MELANCHOR Understanding the Role of Motors in Subcellular Mechanics of Organelles by Controlling Myo6-Cargo Interactions in situ | 2018 | 185˙076.00 | 185˙076.00 |
| 23 | CENEVO A new paradigm for centromere biology:Evolution and mechanism of CenH3-independent chromosome segregation in holocentric insects | 2018 | 1˙497˙500.00 | 1˙497˙500.00 |
| 24 | FUCTURE Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 | 173˙076.00 | 173˙076.00 |
| 25 | MICROBAR Microsatellite Barcoding: reconstructing the family tree of hematopoietic cells | 2018 | 1˙500˙000.00 | 1˙500˙000.00 |
| 26 | METCLL Discovery and validation of ‘epidrivers’ of cancer evolution and resistance to therapy | 2018 | 264˙668.00 | 264˙668.00 |
| 27 | INCPRINT-DRUG incPRINT as a platform for RNA-targeted drug discovery | 2019 | 150˙000.00 | 150˙000.00 |
| 28 | VESSEL CO-COPTION Vessel co-option and radioresistance in glioblastoma | 2019 | 1˙499˙823.00 | 1˙499˙823.00 |
| 29 | RNAFATE RNAfate- revealing regulation of cellular “noise”. | 2019 | 173˙076.00 | 173˙076.00 |
| 30 | NEUCREST Training European Experts in Multiscale Studies of Neural Crest Development and Disorders: from Patient to Model Systems and Back again. | 2019 | 4˙156˙404.00 | 4˙156˙404.00 |
| 31 | PROSTATOR Reliable urinary test for the diagnosis of prostate cancer | 2020 | 0.00 | 150˙000.00 |
| 32 | MIMIC Deciphering how microbiota modulate anti-tumor immune responses in checkpoint therapy | 2020 | 184˙707.00 | 184˙707.00 |
| 33 | GROWTHDEVSTABILITY Characterization of the developmental mechanisms ensuring a robust symmetrical growth in the bilateral model organism Drosophila melanogaster | 2020 | 184˙707.00 | 184˙707.00 |
| 34 | EURECA Institut Curie EuReCa PhD Programme | 2020 | 6˙346˙080.00 | 3˙173˙040.00 |
More Horizon 2020 projects
The Institution INSTITUT CURIE has been involved also in the following Horizon 2020 projects.
- IDEAS (2015, participant)
- BRIDGES (2015, participant)
- PANCANRISK (2015, participant)
- BIOPOL (2015, participant)
- RADIATE (2015, participant)
- LIBRA (2015, participant)
- MIMIC (2016, partner)
- DIVIDE (2016, participant)
- PROTEINCONJUGATES (2015, participant)
- POLARNET (2015, participant)
- GLOBAL BIOIMAGING (2015, participant)
- XPRESS (2015, participant)
- RETUBI (2016, participant)
- PRECISE (2016, participant)
- INTREPID (2017, partner)
- ITCC-P4 (2017, participant)
- CATCH-U-DNA (2017, participant)
- INDEX (2017, participant)
- TRAIN-EV (2017, participant)
- EDIREX (2018, participant)
- INSPIRE (2018, participant)
- BIGMEDILYTICS (2018, participant)
- EPISYSTEM (2018, participant)
- IMMUNAID (2018, participant)
- MYOCHIP (2018, participant)
- CHROMDESIGN (2018, participant)
- STARNEL (2018, participant)
- IPC (2019, participant)
- EUCANCAN (2019, participant)
- LIFETIME (2019, participant)
- IMMUCAN (2019, participant)
- ARCH (2019, participant)
- THERADNET (2019, participant)
- CELL2CELL (2019, participant)
- ONCNGS (2020, participant)